All companies
West Pharmaceutical Services logo

What smart money is saying about West Pharmaceutical ServicesUnited States flag

WST · Healthcare · Medical - Instruments & Supplies · Market cap $24.72B

3 funds in our archive have pitched West Pharmaceutical Services — most recently Generation IM Global Equity Strategy in July 2026.

Company profile

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.

Get an email when a fund writes about it

Summarize with Warren AI
4
Reported positions
1
Bought
0
Sold
7
Letters

Position history

Between Q2 2025 and Q3 2026, 4 fund letters reported a position in West Pharmaceutical Services1 opened or added to the position.

Fund letters reporting a position in West Pharmaceutical Services, by quarter
QuarterLettersBoughtSoldTheses
Q3 20260001
Q2 20263000
Q1 20261100
Q3 20250001
Q2 20250001

Fund activity · 4 positions · 1 move

  • HoldsFindlay Park American Fund
    June 2026
    West Pharmaceutical Services and Waters benefited from accelerating organic revenue growth and improved guidance.
    Read the letterWest Pharmaceutical Services
  • HoldsArtisan Partners Global Discovery Fund
    June 2026
    West Pharmaceutical is a leading provider of injectable drug packaging solutions.
    Read the letterWest Pharmaceutical Services
  • HoldsArtisan Partners Global Opportunities Fund
    June 2026
    Argenx, West Pharmaceutical and Eli Lilly were among the strongest contributors, benefiting from company-specific profit cycles tied to differentiated therapies, improving demand visibility and solid execution.
    Read the letterWest Pharmaceutical Services
  • AddedBrown Advisory U.S. Small-Cap Blend UCITS Fund
    March 2026
    Concerns over potential share losses to oral weight loss drugs and an unexpected CEO retirement announcement sent shares of West Pharmaceutical (WST) lower, offering an attractive entry point to a company we know well.
    Read the letterWest Pharmaceutical Services

Fund coverage · 3 theses

  • Generation IM Global Equity Strategy
    July 2026

    West Pharmaceutical Services makes injectable-drug packaging components and is attractive for its entrenched market share, regulatory and biologics tailwinds, high margins, and strong management.

    Read the full thesis
  • Upslope Capital
    September 2025

    West Pharmaceutical Services is a leading producer of injectable drug delivery components, poised for continued growth due to advancements in drug development and reshoring trends, with a valuation that appears reasonable despite its historical premium.

    Read the full thesis
  • Brasada CM
    June 2025

    West Pharmaceutical’s steep sell-off masks a fundamentally resilient business with irreplaceable components, long-term tailwinds in biologics and GLP-1s, and a compelling setup for patient investors.

    Read the full thesis

Read every full thesis on West Pharmaceutical Services

Unlock all 3 theses — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.

View plans
Share this ledger